StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson Apr 14, 2020 2:22pm

39 Views

Post# 30908325

RE:RE:RE:Somebody at the TD is on the BUY at 0,06$

Yup, the likelihood is that the company put out BS news to pull up the price, liquidate a bunch of shares at that inflated price, and then got out. Meanwhile, you are holding onto "hope" that this will rocket. No doubt the price will fluctuate a few pennies up and down, but it is not some magical company here that is doing something unheard of. They are positioning themselves to talk about offering services. They don't even have a COVID test. They don't have much of anything.